FORMULATION, FILL & FINISH

SPEAKERS INCLUDE

 

Jean Rene Authelin

Jean-René Authelin

Global Head of Pharmaceutical Engineering

 Sanofi

Tudor Arvinte

Tudor Arvinte

CEO, Therapeomic Inc. Basel Professor

University of Geneva 

jennifer mcmanus

Jennifer McManus

Lecturer, Department of Chemistry,

Maynooth University

Ahmed Besheer

Ahmed Besheer

Group Head NBE Formulation Development – Biologics Drug Product Development

Novartis 

lea ann dailey

Lea Ann Dailey

Professor in Biopharmacy

The Martin-uther Univer sität Halle-Witteberg

shahid uddin

Shahid Uddin 

Head of formulation 

Medimmune

 

FORMULATION, FILL & FINISH

Formulation fill and finish equipment

Fill and finish equipment

Downstream processing equipment

Speaker presentations include:

 

Formulation – High concentration biologics and advanced formats
Chaired by: Shahid Uddin , Head of Formulation, MedImmune

Formulation and analytical challenges in developing biosimilars
• Importance of orthogonal analytical methods
• Evaluation of different drug substance (DS) manufacturing methods
• Screening of drug product (DP) formulations identical or similar to originator
• Study and comparison of formulation ingredients
• Comparison of different batches of originator and biosimilar DP
• Studies of  formulation interactions with human plasma and blood

Tudor Arvinte , CEO, Therapeomic Inc. Basel, Professor, University of Geneva

Aggregation analysis at high and low protein concentrations
• Aggregation of proteins may occur by a number of different mechanisms, which can lead to a range of aggregate types
• Using a range of analytical techniques, the formation of protein aggregates by various mechanism has been assessed at low and where possible, at moderate to high protein concentrations
• The effect of sugars on protein stability will also be discussed

Jennifer McManus , Senior Lecturer in Chemistry, Maynooth University

 

Formulation – Stability and longevity Adsorption to filter membranes: relevance for administration and manufacturing
• Filtratration is an important processing step, which a formulated biologic can experience at different stages throughout its lifetime (manufacturing of fully-formulated DS and fill and finish for DP, administration in a clinical setting)
• Adsorption to filter membranes is one of the common incompatibilities during DP administration in a clinical setting. Finding correlations can help in simplifying compatibility studies.
• Adsorption to filter membranes during sterile filtration is one of the critical process attributes. Down scale models will be discussed.

Ahmed Besheer , Group Head NBE Formulation Development – Biologics Drug Product Development, Novartis 

DOWNLOAD THE PROSPECTUS

KEY TOPICS IN 2017

Formulation of high concentration biologics

Formulation of advanced formats

Formulation to ensure stability and longevity

Novel filling technologies

Analytics and quality control for fill and finish

Labelling and logistics

Integrated approaches and processing

 

APPLY TO SPEAK

  •   WHO ATTENDS?

    Head of formulation

    Head of processing and technology

    Head of drug devices

    Head of technical services bio-therapeutics

    DOWNLOAD THE BROCHURE

  • WHO SPONSORS?

    CMOs

    Containment and Sealing 

    Drug Delivery systems

    EQM and technical supply for Formulation, mixing, aeseptic/ sterile processing,lyophilisation

    Couriers / Logistics

    Packaging

    SPONSOR NOW

WHY SPONSOR?

 

Since 1988 the world’s leading brands have sponsored Terrapinn’s events. Established brands use our events to consolidate their position, grow their market share, or enter new sectors or territories. Challenger brands use our events to demonstrate thought leadership, establish their point of difference, and win over new customers.

 

The conference will help you:


Maintain and strengthen existing relationships with key clients and customers
Demonstrate thought leadership, often through speaking positions
Consolidate or raise the profile of their brand
Generate new sales leads

 

All of these help our clients:


Enter a new territory or a new sector
Consolidate and strengthen an existing position against competition
Grow their market share
Help solve a public relations challenge
Talk to us today about how we can help your business development, marketing and communications plan for 2017 and beyond.‚Äč

  •  

     

    Bringing together future technologies and systems for innovative partnerships

     

     

     

  •  

     

    Visionary keynotes

    Inspiring case studies

    Collaborative networking opportunities 

     

  •  

     

     

     

     The perfect platform to find solutions to aid your biomanufacturing production.

    DOWNLOAD BROCHURE

     

     

DOWNLOAD THE PROSPECTUS

Download the prospectus to view past attendees, sponsorship opportunities, testimonials, sponsor and exhibition packages, the floorplan and more! Find a package suitable for you at the biomanufacturing & bioprocessing event of the year.

DOWNLOAD THE PROSPECTUS

 

 


GET INVOLVED

 

To sponsor or exhibit contact:  Toby Lomax  
Tel: +44 (0)20 7092 1249
email: toby.lomax@terrapinn.com

To speak, contact: Joan Shutt  
Tel: +44 207 092 1134
email: joan.shutt@terrapinn.com